Aurora Therapeutics
13 employees on LinkedIn · 1 known investors
Find your way into Aurora Therapeutics
Sign up to find every way you can get introduced to Aurora Therapeutics
- Your email: who you already know at Aurora Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Aurora Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Aurora develops a platform for personalized gene editing to treat rare genetic diseases at scale. The company targets patients with rare disease variants by systematizing and scaling gene editing treatments to address genetic mutations that lack existing therapeutic options.
Investors · 1
How we know: Menlo Ventures's portfolio page · a partner's Signal profile · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$16M disclosed across 1 round · 2026
- $16MSeedFeb 2026Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Related companies · 3
Companies working in the same space as Aurora Therapeutics.
Frequently asked questions
- What does Aurora Therapeutics do?
- Aurora develops a platform for personalized gene editing to treat rare genetic diseases at scale. The company targets patients with rare disease variants by systematizing and scaling gene editing treatments to address genetic mutations that lack existing therapeutic options.
- Who are Aurora Therapeutics's investors?
- Aurora Therapeutics's investors include Menlo Ventures.
- How much funding has Aurora Therapeutics raised?
- Aurora Therapeutics has disclosed $16M raised across 1 round.


